在学龄儿童的儿科临床试验环境中诊断新发喘
Graham Roberts1,2,3, Erkka Valovirta4, Susanne Halken5
1The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, United Kingdom.
Frontiers in allergy
|July 31, 2024
概括
诊断儿童喘需要一致的标准. 这项研究提出了一种分层方法"可能,可能和证实"以提高喘预防临床试验的准确性.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床试验设计 临床试验设计
- 喘诊断 喘的诊断 喘的诊断
背景情况:
- 儿童喘是一种常见的,动态的疾病,症状和测试结果各不相同.
- 目前的诊断标准缺乏一致性,挑战了喘预防试验的有效性.
- 单点评估可能导致儿科喘的诊断不准确.
研究的目的:
- 审查目前对学龄儿童新发喘的诊断标准.
- 为未来儿童喘预防试验提出改进的诊断标准.
- 在研究环境中提高儿童喘诊断的准确性和一致性.
主要方法:
- 关于儿童喘诊断的已发表的临床指南的全面审查.
- 在儿童喘预防试验中使用的诊断标准的分析.
- 开发一个分层的诊断框架 (可能的,可能的,确定的).
主要成果:
- 在当前的临床指南中,对于儿科喘诊断缺乏共识.
- 共同的要素包括评估可变的症状和肺功能.
- 提出的一种分层方法是根据症状,可逆性和对治疗的反应对喘进行分类.
结论:
- 儿童喘预防试验需要改进诊断标准.
- 一个分层系统 (可能的,可能的,确定的) 可以提高诊断准确性.
- 这些建议将有助于设计和开展未来的儿科喘研究.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
Asthma: Pathogenesis and Management
379
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
379
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
244
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
244


